MRONJ of the Mandible-From Decortication to a Complex Jaw Reconstruction Using a CAD/CAM-Guided Bilateral Scapula Flap
- PMID: 36984535
- PMCID: PMC10052135
- DOI: 10.3390/medicina59030535
MRONJ of the Mandible-From Decortication to a Complex Jaw Reconstruction Using a CAD/CAM-Guided Bilateral Scapula Flap
Abstract
Medication-related osteonecrosis of the jaw (MRONJ) has been an integral part of the maxillofacial patient population for some time. The therapeutic concept ranges from conservative approaches over less extended decortications to major jaw resections, which can result in a considerable loss of quality of life. Based on three case reports, this paper presents the long-term history of patients with MRONJ of the mandible, whose disease ultimately resulted in partial or total mandibular resection and subsequent multisegmental reconstruction using a microvascular anastomosed bone flap. Furthermore, a suitable alternative for complex mandibular reconstruction is demonstrated when using a free fibula flap is not possible. The options are limited, particularly when multisegmental restoration of mandibular continuity is required. One case presents a mandible reconstruction using a CAD/CAM-guided bilateral scapular free flap (CAD/CAM = Computer-Aided Design and Manufacturing), which has not been described for this purpose before. Due to the complexity, computer-assisted surgery and patient-specific implants seem reasonable, which is why a special focus was applied to this topic.
Keywords: CAD/CAM; MRONJ; PSI; free flap; mandibular reconstruction.
Conflict of interest statement
The authors declare no conflict of interest.
Figures













References
-
- Christodoulou C., Pervena A., Klouvas G., Galani E., Falagas M.E., Tsakalos G., Visvikis A., Nikolakopoulou A., Acholos V., Karapanagiotidis G., et al. Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone. Oncology. 2009;76:209–211. doi: 10.1159/000201931. - DOI - PubMed
-
- Sivolella S., Lumachi F., Stellini E., Favero L. Denosumab and Anti-Angiogenetic Drug-Related Osteonecrosis of the Jaw: An Uncommon but Potentially Severe Disease. Anticancer Res. 2013;33:1793–1797. - PubMed
-
- Papapoulos S., Lippuner K., Roux C., Lin C.J.F., Kendler D.L., Lewiecki E.M., Brandi M.L., Czerwiński E., Franek E., Lakatos P., et al. The Effect of 8 or 5 Years of Denosumab Treatment in Postmenopausal Women with Osteoporosis: Results from the FREEDOM Extension Study. Osteoporos. Int. 2015;26:2773–2783. doi: 10.1007/s00198-015-3234-7. - DOI - PMC - PubMed
-
- Stopeck A.T., Fizazi K., Body J.-J., Brown J.E., Carducci M., Diel I., Fujiwara Y., Martín M., Paterson A., Tonkin K., et al. Safety of Long-Term Denosumab Therapy: Results from the Open Label Extension Phase of Two Phase 3 Studies in Patients with Metastatic Breast and Prostate Cancer. Support. Care Cancer. 2016;24:447–455. doi: 10.1007/s00520-015-2904-5. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous